[Pharmacokinetic studies with radioactive labeled N-(n-propyl)-ajmaline-hydrogentartrate].
D000404:Ajmaline / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D000818:Animals; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000378:metabolism; D051381:Rats; D013045:Species Specificity; D014316:Tritium
D000644:Quaternary Ammonium Compounds; D014316:Tritium; D000404:Ajmaline
Pharmakokinetische Studien mit radioaktiv markiertem N-(n-propyl)-Ajmalinium-hydrogentartrat